Target intelligence / Profile preview

Curcuminoids

Molecular classification
Polyphenol, Diarylheptanoid, Natural product
01

Overview

Curcuminoids are a group of natural polyphenolic compounds found in the rhizome of turmeric (Curcuma longa), with curcumin being the most prominent and bioactive member. They are characterized by their diarylheptanoid structure and are widely recognized for their potent anti-inflammatory, antioxidant, and anti-neoplastic properties. In a pharmacological context, curcuminoids are considered bioactive ligands or drug candidates rather than therapeutic targets themselves. They exert their biological effects by interacting with a vast array of molecular targets, including transcription factors like NF-κB, enzymes such as cyclooxygenase-2 (COX-2), and various growth factor receptors. Despite their therapeutic potential in treating chronic inflammatory diseases and certain cancers, their clinical utility is often limited by poor aqueous solubility, low systemic bioavailability, and a tendency to interfere with laboratory assays, leading to their classification as Pan-Assay Interference Compounds (PAINS).

Other names
Turmeric polyphenolsDiarylheptanoidsCurcuminoid mixture
02

Mechanism of action

Curcuminoids act as pleiotropic modulators of multiple signaling pathways rather than binding to a single target; they inhibit NF-kappaB activation, downregulate pro-inflammatory enzymes like COX-2 and 5-LOX, and modulate various protein kinases and transcription factors (e.g., STAT3, AP-1).

03

Biological functions

Antioxidant activityAnti-inflammatory signaling modulationApoptosis inductionFree radical scavenging
04

Disease associations

InflammationCancerNeurodegenerative diseaseMetabolic syndromeArthritis
05

Safety considerations

Poor bioavailabilityRapid metabolism and excretionChemical instability (PAINS properties)Potential for drug-drug interactions via CYP450 inhibitionGastrointestinal distress at high doses
06

Interacting drugs

Curcumin

2 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)Malondialdehyde (MDA)

Beyond the preview

Go deeper on Curcuminoids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Curcuminoids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call